Download PDF
Thromb Haemost 1988; 60(02): 324-327
DOI: 10.1055/s-0038-1647054
Original Article
Schattauer GmbH Stuttgart

Induction of Fibrinolysis by Polyanions in Human Plasma

Rainer J Klauser
The Luitpold-Werk, Munchen, FRG
› Author Affiliations
Further Information

Publication History

Received 07 December 1987

Accepted after revision 01 July 1988

Publication Date:
28 June 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

The fibrinolytic potency of several polyanions was comparatively investigated. Fibrinolytic activity was measured in a whole plasma assay using H-D-Val-Leu-Lys-pNA (S-2251) as chromogenic substrate and by a fibrin plate assay using plasminogen rich fibrin plates.

In the chromogenic substrate assay potent fibrinolytic polyanions comprised dextran sulfate, GAGPS, pentosan polysulfate, polyanethol sulfate, 1-carrageenan and i-carrageenan. Chon- droitin sulfates A, B, ‘C, keratan sulfate, ribonucleic acid, k-carrageenan and heparin were weakly fibrinolytic. Hyaluronic acid and lipopolysaccharide from E. coli were inactive.

Similar results were obtained when fibrinolytic activity was measured by a fibrin plate assay. All polyanions except lipopolysaccharide produced lysis zones.

Induction of fibrinolytic activity in human plasma was shown to be at least partially dependent on Hageman factor. In factor XII deficient plasma no fibrinolysis was induced by any of the polyanions when measured in the fibrin plate assay.

In the. chromogenic substrate assay corn Hageman factor inhibitor (CHFI) inhibited the activation of S-2251 cleaving enzyme by GAGPS, pentosan poly sulfate, polyanethol sulfate, heparin, and ribonucleic acid near completely. The activation by dextran sulfate was inhibited by 45%.

Heparin, pentosan polysulfate and GAGPS, three poly anions of therapeutic interest were separately compared. In both assays GAGPS proved the most potent activator, while pentosan poly sulfate exhibited 83% and 44% and heparin 32% and 14% of GAGPS fibrinolytic activity in the chromogenic substrate test and the fibrin plate assay, respectively.

Keywords

Fibrinolysis - Hageman factor - Polyanions - Sulfated polysaccharides
 

  • References

  • 1 Ungar G, Mist SH. Observations on the release of serum fibrinolysin by specific antigen, peptone and certain polysaccharides. Exp Med 1949; 90: 39-51
    CrossrefPubMedSearch in Google Scholar
  • 2 v. Kaulla KN, McDonald TS. The effect of heparin on components of the human fibrinolytic system. Blood 1958; 13: 811-821
    PubMedSearch in Google Scholar
  • 3 Halse T. Aktivierung der Fibrinolyse und Thrombolyse durch Polysac- charidschwefelsaurester (Heparin, Heparinoide). Arzneim-Forsch 1961; 13: 574-582
    PubMedSearch in Google Scholar
  • 4 Olesen ES. A fibrinolytic system in human plasma activated by peptone or acide polysaccharides. Scand J Clin Lab Invest 1961; 13: 410-415
    CrossrefPubMedSearch in Google Scholar
  • 5 Rosa AT, Rothschild AM, Rothschild Z. Fibrinolytic activity evoked in the plasma of the normal and adrenalectonized rat by cellulose sulfate. Br J Pharmacol 1972; 45: 470-475
    CrossrefPubMedSearch in Google Scholar
  • 6 Kluft C. Studies on the fibrinolytic system in human plasma: Quantitative determination of plasminogen activators and proactivators. Thromb Haemostas 1979; 41: 365-383
    PubMedSearch in Google Scholar
  • 7 Vinazzer H, Stemberger A, Haas S, Blümel G. Influence of heparin of different heparin fractions and of a low molecular weight heparinlike substance on the mechanism of fibrinolysis. Thromb Res 1982; 27: 341-352
    CrossrefPubMedSearch in Google Scholar
  • 8 Markwardt F, Klöcking HP. Heparin induced release of plasminogen activator. Haemostasis 1977; 6: 370-374
    PubMedSearch in Google Scholar
  • 9 Vairel EG, Brouty-Boye H, Toulemonde F. Increase of plasminogen activator release by heparins and other sulphated polysaccharides. Prog Fibrinolysis 1983; 6: 577-580
    PubMedSearch in Google Scholar
  • 10 Hojima Y, Pierce JV, Pisano J J. Hageman factor fragment inhibitor in corn seeds: Purification and characterization. Thromb Res 1980; 20: 149-162
    CrossrefPubMedSearch in Google Scholar
  • 11 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin-phenol reagent. J Biol Chem 1951; 193: 265-275
    PubMedSearch in Google Scholar
  • 12 Fritz H, Trautschold I, Werle E. Protease-Inhibitoren. In: Methoden der enzymatischen Analyse Bergmeyer HU. (ed) Bd I 1105-1122 Verlag Chemie; Weinheim: 1970
    Search in Google Scholar
  • 13 Brakman P, Astrup T. The fibrin plate method for assay of fibrinolytic agents. In: Thrombosis and BleedingDisorders Bang NU, Beller FK, Deutsch E, Mammen EF. (eds) Academic Press; New York: 1971: 332
    Search in Google Scholar
  • 14 Kluft C, Trumpi-Kalshoven MM, Jie AF H, Veldhuyzen-Stolk EC. Factor XII dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII and kallikrein dependent plasminogen proactivator. Thromb Haemostas 1979; 41: 756-773
    PubMedSearch in Google Scholar
  • 15 Astrup T, Rosa AT. A plasminogen proactivator-activator system in human blood effective in the absence of Hageman factor. Thromb Res 1974; 4: 609-613
    CrossrefPubMedSearch in Google Scholar
  • 16 Hojima Y, Cochrane CG, Wiggins RC, Austen KF, Stevens RL. In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E. Blood 1984; 63: 1453-1459
    PubMedSearch in Google Scholar
  • 17 Shimada T, Sugo T, Kato H, Yoshida K, Iwanaga S. Activation of factor XII and prekallikrein with polysaccharide sulfates and sul- fatides: comparison with kaolin-mediated activation. J Biochem (Tokyo) 1985; 97: 429-439
    CrossrefPubMedSearch in Google Scholar
  • 18 Kaplan AP, Austen KF. The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator. J Exp Med 1972; 136: 1378-1393
    CrossrefPubMedSearch in Google Scholar